Markus Schlaich

Clinical researcher
The University of Western Australia - Perth, Australia

Latest contributions

Innovative approaches to refractory heart failure: devices and therapies to the rescue

23 May 2025 – From EuroPCR 2025

This session highlights innovative device-based therapies for refractory heart failure, emphasizing the integration of neuromodulation, decongestive strategies, and the synergy with pharmacological treatments. Case presentations illustrate the evolving landscape of advanced heart failure management.

Innovative approaches to refractory heart failure: devices and therapies to the rescue

Novelties and future developments of sympathetic denervation to control blood pressure

21 May 2025 – From EuroPCR 2025

Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.

Novelties and future developments of sympathetic denervation to control blood pressure

Symplicity Spyral renal denervation: more insights from clinical practice

21 May 2025 – From EuroPCR 2025

Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...

Symplicity Spyral renal denervation: more insights from clinical practice

Update on renal denervation

16 May 2023 – From EuroPCR 2023

Check out these slides if you want to refresh your memory regarding this session presenting an update on renal denervation.

Renal denervation procedures